With surface modification by the epidermal growth factor receptor targeting peptide GE11, the prepared nanoparticles could efficiently accumulate in tumor tissue and significantly inhibit tumor growth (Xin et al., 2020). The gene discussed is EGFR; the disease is neoplasm.